New Delhi, Sep 25: For the month of August 2026, Central Drugs Laboratories have identified 29 Drug Samples to be Not of Standard Quality (NSQ) and State Drugs Testing Laboratories have identified 191 Drug Samples as Not of Standard Quality (NSQ).
Further, 01 Drug sample from NCT Delhi is identified as spurious drug, which was manufactured by unauthorised manufacturers using a brand name owned by another company. Details with CTN read as under:-
|